Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 2
1957 4
1958 12
1959 8
1962 3
1968 1
2001 1
2005 1
2008 1
2010 3
2011 1
2012 7
2013 3
2014 5
2015 5
2016 4
2017 7
2018 11
2019 5
2020 14
2021 4
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
de Haas SL, Slamon DJ, Martin M, Press MF, Lewis GD, Lambertini C, Prat A, Lopez-Valverde V, Boulet T, Hurvitz SA. de Haas SL, et al. Among authors: lambertini c. Breast Cancer Res. 2023 Jan 11;25(1):2. doi: 10.1186/s13058-022-01587-z. Breast Cancer Res. 2023. PMID: 36631725 Free PMC article. Clinical Trial.
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
Huober J, Barrios CH, Niikura N, Jarząb M, Chang YC, Huggins-Puhalla SL, Pedrini J, Zhukova L, Graupner V, Eiger D, Henschel V, Gochitashvili N, Lambertini C, Restuccia E, Zhang H; IMpassion050 Trial Investigators. Huober J, et al. Among authors: lambertini c. J Clin Oncol. 2022 Sep 1;40(25):2946-2956. doi: 10.1200/JCO.21.02772. Epub 2022 Jun 28. J Clin Oncol. 2022. PMID: 35763704 Free PMC article. Clinical Trial.
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.
Denkert C, Lambertini C, Fasching PA, Pogue-Geile KL, Mano MS, Untch M, Wolmark N, Huang CS, Loibl S, Mamounas EP, Geyer CE, Lucas PC, Boulet T, Song C, Lewis GD, Nowicka M, de Haas S, Basik M. Denkert C, et al. Among authors: lambertini c. Clin Cancer Res. 2023 Apr 14;29(8):1569-1581. doi: 10.1158/1078-0432.CCR-22-1989. Clin Cancer Res. 2023. PMID: 36730339 Free PMC article.
ECG of the Month.
Romito G, Lambertini C, Mazzanti A, Mazzoldi C, Romagnoli N, Cipone M. Romito G, et al. Among authors: lambertini c. J Am Vet Med Assoc. 2022 May 4;260(15):1-3. doi: 10.2460/javma.21.01.0038. J Am Vet Med Assoc. 2022. PMID: 35507515 No abstract available.
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
Loibl S, Huang CS, Mano MS, Mamounas EP, Geyer CE Jr, Untch M, Thery JC, Schwaner I, Limentani S, Loman N, Lübbe K, Chang JC, Hatschek T, Tesarowski D, Song C, Lysbet de Haas S, Boulet T, Lambertini C, Wolmark N. Loibl S, et al. Among authors: lambertini c. NPJ Breast Cancer. 2022 Sep 19;8(1):106. doi: 10.1038/s41523-022-00477-z. NPJ Breast Cancer. 2022. PMID: 36117201 Free PMC article.
Behavioral Assessment of Vision in Pigs.
Barone F, Nannoni E, Elmi A, Lambertini C, Scorpio DG, Ventrella D, Vitali M, Maya-Vetencourt JF, Martelli G, Benfenati F, Bacci ML. Barone F, et al. Among authors: lambertini c. J Am Assoc Lab Anim Sci. 2018 Jul 1;57(4):350-356. doi: 10.30802/AALAS-JAALAS-17-000163. Epub 2018 Jul 2. J Am Assoc Lab Anim Sci. 2018. PMID: 29966544 Free PMC article.
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.
Pietrantonio F, Manca P, Bellomo SE, Corso S, Raimondi A, Berrino E, Morano F, Migliore C, Niger M, Castagnoli L, Pupa SM, Marchiò C, Di Bartolomeo M, Restuccia E, Lambertini C, Tabernero J, Giordano S. Pietrantonio F, et al. Among authors: lambertini c. Clin Cancer Res. 2023 Feb 1;29(3):571-580. doi: 10.1158/1078-0432.CCR-22-2533. Clin Cancer Res. 2023. PMID: 36413222 Free PMC article.
Cosmopolitan Species As Models for Ecophysiological Responses to Global Change: The Common Reed Phragmites australis.
Eller F, Skálová H, Caplan JS, Bhattarai GP, Burger MK, Cronin JT, Guo WY, Guo X, Hazelton ELG, Kettenring KM, Lambertini C, McCormick MK, Meyerson LA, Mozdzer TJ, Pyšek P, Sorrell BK, Whigham DF, Brix H. Eller F, et al. Among authors: lambertini c. Front Plant Sci. 2017 Nov 16;8:1833. doi: 10.3389/fpls.2017.01833. eCollection 2017. Front Plant Sci. 2017. PMID: 29250081 Free PMC article. Review.
Differential liver histopathological responses to amphibian chytrid infection.
Salla RF, Jones-Costa M, Abdalla FC, Vidal FAP, Boeing GANS, Oliveira CR, Silva-Zacarin ECM, Franco-Belussi L, Rizzi-Possignolo GM, Lambertini C, Toledo LF. Salla RF, et al. Among authors: lambertini c. Dis Aquat Organ. 2020 Dec 17;142:177-187. doi: 10.3354/dao03541. Dis Aquat Organ. 2020. PMID: 33331285
115 results